NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
424B3 - Moleculin Biotech, Inc.
Filed:
2026-04-14
AccNo:
0001437749-26-012262
Size:
115 KB
发布时间04/14 20:56 UTC
首次发现04/14 21:00 UTC
热度102.7
重要度38
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 525 字符
Form 424B3 - Prospectus [Rule 424(b)(3)]: SEC Accession No. 0001437749-26-012262
Filing Date: 2026-04-14
Accepted: 2026-04-14 16:56:35
Documents: 2
Moleculin Biotech, Inc. (Filer) CIK : 0001659617 (see all company filings) EIN. : 474671997 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B3 | Act: 33 | File No.: 333-294686 | Film No.: 26861451 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 424B3 | mbrx20260409_424b3.htm | 424B3
2 | mbrx20260409_424b3img001.jpg | GRAPHIC | 5116